Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

被引:7
|
作者
Roth, Alexander
Barcellini, Wilma
D'Sa, Shirley
Miyakawa, Yoshitaka
Broome, Catherine M.
Michel, Marc
Kuter, David J.
Jilma, Bernd
Tvedt, Tor Henrik Anderson
Lin, Stella
Jiang, Xiaoyu
Reuter, Caroline
Hobbs, William
Berentsen, Sigbjorn
机构
关键词
D O I
10.1182/blood-2019-132490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
LBA-2
引用
收藏
页数:4
相关论文
共 50 条
  • [1] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2020, 105 : S38 - S38
  • [2] Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    Sa, D. S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, Anderson T. H.
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 177 - 177
  • [3] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): INTERIM RESULTS OF THE PHASE 3 CARDINAL STUDY LONG -TERM FOLLOW-UP
    Barcellinia, W.
    Roeth, A.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Weitz, I. C.
    Patel, P.
    Jiang, X.
    Reuter, C.
    Su, J.
    Shafer, F.
    Lee, M.
    Hobbsb, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 107 - 107
  • [4] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Patel, Parija
    Jiang, Xiaoyu
    Reuter, Caroline
    Su, Jun
    Shafer, Frank
    Lee, Michelle
    Hobbs, William
    Berentsen, Sigbjorn
    [J]. BLOOD, 2020, 136
  • [5] Interim results of the phase 3 CARDINAL study long-term follow-up: Inhibition of complement C1s with sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C.
    Michel, M.
    Kuter, D.
    Jilma, B.
    Tvedt, T. H. A.
    Weitz, I. C.
    Patel, P.
    Jiang, X.
    Reuter, C.
    Su, J.
    Shafer, F.
    Lee, M.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 169 - 170
  • [6] Sutimlimab, a complement C1s inhibitor, improves quality of life in patients with cold agglutinin disease: Patient-reported outcomes results of the phase 3 cardinal study
    Roeth, A.
    Barcellini, W.
    Tvedt, Anderson T. H.
    Miyakawa, Y.
    Kuter, D. J.
    Hobbs, W.
    Su, J.
    Jiang, X.
    Arias, Morales J.
    Weitz, I. C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 179 - 180
  • [7] SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
    Barcellini, W.
    Roth, A.
    Tvedt, T. H. Anderson
    Miyakawa, Y.
    Kuter, D. J.
    Hobbs, W.
    Su, J.
    Jiang, X.
    Morales Arias, J.
    Weitz, I. C.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 111 - 112
  • [8] Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease
    Roeth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Yoo, Ronnie
    Jayawardene, Deepthi
    Vagge, Deepthi S.
    Kralova, Katarina
    Shafer, Frank
    Wardecki, Marek
    Lee, Michelle
    Berentsen, Sigbjorn
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1246 - 1253
  • [9] Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
    Roeth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Patel, Parija
    Jiang, Xiaoyu
    Reuter, Caroline
    Su, Jun
    Shafer, Frank
    Lee, Michelle
    Berentsen, Sigbjorn
    [J]. HAEMATOLOGICA, 2022, 107 (07) : 1698 - 1702
  • [10] Inhibition of complement C1s by sutimlimab (SUT) in patients with cold agglutinin disease (CAD): results on efficacy and safety from the randomized, placebo-controlled phase 3 CADENZA study (NCT03347422)
    Roeth, A.
    Berentsen, S.
    Barcellini, W.
    D'Sa, S.
    Jilma, B.
    Michel, M.
    Weitz, I. C.
    Yamaguchi, M.
    Nishimura, J. -i
    Vos, J. M.
    Storek, M.
    Wong, N. W.
    Patel, P.
    Jiang, X.
    Vagge, D.
    Wardecki, M.
    Shafer, F.
    Lee, M.
    Broome, C. M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 172 - 173